Skip to main content
. 2016 Dec 29;11(12):e0168117. doi: 10.1371/journal.pone.0168117

Table 4. Odds ratio of rapid progression for a panel of uremic solutes.

Uremic Solute Crude Adjusted
OR 95% CI OR 95% CI
CMPF 0.78 0.48 - 1.29 0.94 0.49 - 1.81
Hippuric acid 1.20 0.76 - 1.90 1.50 0.77 - 2.93
Indole acetic acid 1.25 0.78 - 2.01 2.07 1.07 - 4.02
Indoxyl sulfate 0.84 0.52 - 1.33 0.96 0.54 - 1.70
Kynurenic acid 1.42 0.83 - 2.42 1.39 0.66 - 2.91
Kynurenine 1.24 0.78 - 1.99 1.37 0.76 - 2.48
Quinolinic acid 1.46 0.91 - 2.34 1.21 0.66 - 2.19
p-Cresyl glucuronide 0.90 0.57 - 1.42 0.97 0.51 - 1.84
p-Cresyl sulfate 1.14 0.72 - 1.79 1.38 0.76 - 2.53
Phenyl sulfate 1.12 0.71 - 1.78 1.29 0.72 - 2.32
Tryptophan 0.99 0.63 - 1.57 1.18 0.63 - 2.21

Odds ratios (OR) are presented per incremental SD in uremic solute concentration. The adjusted ORs were obtained from a logistic regression corrected for batch, age, diagnosis (congenital disease present), systolic blood pressure, dietary fiber intake, protein intake, proteinuria and serum albumin concentration at baseline. CMPF: 3-carboy-4-methyl-5-propyl-2-furanpropionate.